Exosens 9M 2026 adjusted gross margin rises 16% to €194.9 million

By Public Technologies
  • Exosens’ nine-month 2026 adjusted gross margin rose 16% year over year to €194.9 million, while its margin rate declined to 50.4%.
  • Revenue climbed 18% year over year to €386.9 million, driven by growing demand for night vision and imaging solutions.
  • U.S. subsidiary Photonis Defense secured its first delivery order for 1,600 complete systems under the U.S. Army’s BiNOD program.
  • The group confirmed 2026 guidance for revenue of €558 million–€570 million and adjusted EBITDA of €186 million–€192 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exosens SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610270215OMX_____CNEWS_EN_GNW1001279946_en) on October 27, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk